TRAC Seminar Series

Session 3

 

Date: April 15, 2005 at 15.00

Place: TRAC Conference hall

 

Title : The influence of aerobic exercice on lipodystrophy, metabolic function and quality of life among adults with HIV infection

 


Abstract:

Background:
The management of HIV infection, and subsequent development of AIDS has evolved since the syndrome was first described. Although the current use of Highly Active Antiretroviral Therapy (HAART) has decreased the mortality and morbidity rates of HIV infected persons, it is associated with lipodystrophy and metabolic dysfunction abnormalities. Patients affected by lipodystrophy can be identified as HIV+ wherever they are in public areas. This serves further stigma as the body wasting and skin lesions in the earlier years of the epidemic. The associated psycho-social problems of low self-esteem and depression, may influence patients’ decisions to start or continue HIV medications. Lipodystrophy may also cause musculo-skeletal disorders, such as neck pain and back pain that may result from fat collections around the neck and breast enlargement respectively. Lipodystrophy is usually accompanied by high cholesterols-TC, LDL (HDL decreases), triglycerides and glucose levels. Metabolic changes alter the function of multiple cell types of endothelium, smooth muscle and platelets resulting into vaso-constrictions, inflammation and thrombosis leading to atherogenesis. This predisposes the affected individuals to premature cardiovascular diseases. There is sufficient evidence to support the benefits of exercise in adults with HIV infection. However, as various types of HAART become available in the most HIV/AIDS stricken developing countries, there are inadequate studies to evaluate and promote aerobic exercise in alleviating HIV lipodystrophy and the related metabolic dysfunction. Objectives: (i) To determine the occurrence and severity of physical changes in body composition associated with lipodystrophy, (ii) To establish the effect of aerobic exercise on aerobic capacity of patients with HIV and lipodystrophy, (iii) To assess the effect of aerobic exercise on lipodystrophy and quality of life in adults with HIV infection, (iv) To determine the effect of HIV and lipodystrophy on lipid and glucose metabolism, and (v) To design weekly aerobic exercise programs and monitor anthropometric measurements, lipid & glucose levels for adults with HIV infection. Design and subjects: A randomised controlled trial of four (4) study groups, each with 50 participants (approximating a drop-out rate of 20%) using a power calculation of 80%. Setting and measurements: After ethical clearance, participants will be recruited from various HIV/AIDS clinics in Kigali City province, Kabyayi Hospital , Butare University Hospital , Centre Hospitalier Universitaire de Kigali (CHK-CHUK) and Treatment & Research AIDS Centre (TRAC). Data analyses: Data analyses will include descriptive statistics, and associations of various variables will be analysed using Chi-square and Fisher’ Exact tests. Differences in means will be given by subtractions of the outcome control from outcome test, using a 95% confidence interval. An accepted Type 1 error probability of five percent (p < 0.05) will be used for statistical significance. Significance: The study will be a contribution to the significance and effect of aerobic exercises on lipodystrophy syndrome and QOL among HIV individuals. The findings could be useful indicators of how non-pharmacological agents can be used for the management of lipodystrophy. Duration and costs: The study will take 48 weeks of data collection, exercise program, while reporting and publications will take about 24 weeks. The cost of the study will be thirty eight millions nine hundred seventy five thousands and five hundred Rwanda Francs (38975500 Frw), 64,959 US$ dollars (1 US $ =600 Frw), most of which will be used for purchase of relevant equipments for the project.

 

 

 

Presenter: Eugene Mutimura

 

 

Eugene Mutimura is a lecturer at Kigali Health Institute. He completed his BSc (Hons) degree and MSc degree from South Africa in 2001. He started his Doctoral studies in 2004 at the University of the Witwatersrand ( South Africa ), with which Kigali Health Institute is establishing a partnership. His PhD studies focus on Randomised controlled trial of aerobic capacity on HIV lipodystrophy and metabolic function”, exploring a possible relationship between aerobic exercise capacity, anthropometric variables and metabolic dysfunction that may occur in lipodystrophy syndrome. In response to public health issues, Eugene has attended and presented at several regional & international conferences. He presented papers on HIV/IDS, such as “Response of Higher Institutions of Learning to the HIV/AIDS Pandemic” and “Psycho-Social and Economic Impact of HIV/AIDS on Education System”. He is currently involved in an intervention on “Strategic approaches to HIV/AIDS Prevention, Care & Rehabilitation of People living with HIV/AIDS”. He presented research papers in June 2004 at the 14th International World Confederation for Physical Therapy in Barcelona , Spain (“The role of caregivers in rehabilitation of their children with disabilities” and “Health promotion needs of physically disabled individuals with lower limb amputation in selected areas of Rwanda ”). In 2003 he presented papers in Cape Town on “Public health consequences of landmines in post war Rwanda andPromotion of Health-enhancing programs for physically handicapped individuals”. Responding to the current public outcry of low back pain in Rwanda , he recently completed a research on ‘Low back pain predictors, its classification and patient satisfaction with management.”.